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Introduction
ELISPOT assays are primarily used to detect the num-
ber of T cells that respond to a given antigen. With that
number being absolute for any given donor sample, ELI-
SPOT counts should be similar between laboratories, if
subjectivity in counting is avoided. Due to the differ-
ences in spot sizes ranging from microns to millimeters,
setting cut offs for minimal and maximal spot sizes will
lead to substantial variability between investigators when
determined subjectively, irrespective of experience. In
contrast, if spot size distributions would follow predict-
able statistical functions, objective gating decisions could
be made using common standards, eliminating subjec-
tive calls of the counting process. This study aims to
determine if ELISPOT size distribution follows predict-
able statistical distributions and therefore if ELISPOT
counting can be made objective based on statistical
principles.
Methods
In order to study whether spot sizes follow predictable
functions, we studied the size distributions of ELISPOT
assay results obtained with 24 donors and 32 individual
viral peptides of Cytomegalovirus, Epstein Barr, and
Influenza virus activating CD8 cells, and the CMV and
EBV virions activating CD4 cells. The spot size distribu-
tions were assessed by morphometric analysis. The assay
results were also analyzed by 10 different laboratories.
Results
The analysis of antigen-elicited ELISPOT sizes for IFN-
g, IL-2, IL-4, IL-5 and IL-17 was found to exhibit a Log-
Normal distribution pattern for all 24 donors, and for
all CD4 and CD8 cell-derived cytokine signatures. The
significance levels were over 5% according to Kolmo-
gorov-Smirnov test. When the spot counts were estab-
lished in 10 different laboratories using gating criteria
established based on Log Normal distributions, the coef-
ficient of variation (CV) of mean spot counts between
different laboratories was 6.7%. In contrast, when the
participating scientists set gates based on subjective
assessment, the CV of mean spot counts obtained
between the different laboratories was 26.7%.
Conclusions
For all 24 donors, 34 antigens, and for all five cytokines
studied, ELISPOTs were observed to follow log normal
distribution. This statistical function permits us to set
upper and lower size gates automatically with a 98%
confidence. Using this statistics-based approach, ten dif-
ferent laboratories obtained close to identical counts, as
opposed to when the gates were set subjectively by the
different investigators. Harmonization of accurate and
objective ELISPOT counts can be accomplished based
on statistical principles.
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